Partial palivizumab prophylaxis and increased risk of hospitalization due to respiratory syncytial virus in a Medicaid population: a retrospective cohort analysis

BACKGROUND: Infection with respiratory syncytial virus (RSV) is common among young children insured through Medicaid in the United States. Complete and timely dosing with palivizumab is associated with lower risk of RSV-related hospitalizations, but up to 60% of infants who receive palivizumab in Me...

Descripción completa

Detalles Bibliográficos
Autores principales: Krilov, Leonard R, Masaquel, Anthony S, Weiner, Leonard B, Smith, David M, Wade, Sally W, Mahadevia, Parthiv J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287588/
https://www.ncbi.nlm.nih.gov/pubmed/25308481
http://dx.doi.org/10.1186/1471-2431-14-261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287588/
https://www.ncbi.nlm.nih.gov/pubmed/25308481
http://dx.doi.org/10.1186/1471-2431-14-261

Ejemplares similares